Mulkalwar Sarita, Khan Uzair, Chitale Shantanu, Tilak Abhijeet, Rane Bhalchandra, Patel Abhi
Dr D Y Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India.
Dr D Y Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, India
Eur J Hosp Pharm. 2024 Dec 30. doi: 10.1136/ejhpharm-2024-004131.
Adverse drug reactions (ADRs) are among the leading standalone causes of morbidity and hospitalisation and contribute substantially to an increase in healthcare expenditure. Repeat ADR events, although difficult to quantify, are a recognised problem that lead to preventable suffering for the patient. The current approaches for the prevention of ADR recurrence in low/middle-income countries range from inefficient to non-existent. There is very little literature that focuses on the preventability of ADRs in such settings. This study aimed to develop the ADR Alert Card, an economical innovation designed as a stop gap in preventing ADR recurrence, and to evaluate its utility by validating the system through input from medical professionals.
The ADR Alert Card was validated and registered with the Copyrights Office of the Government of India. To obtain the opinion of healthcare professionals and gauge the status quo in prevention of ADR recurrence, we conducted an online descriptive cross-sectional study over a period of 6 months.
The survey received 218 responses. Demographics varied, ranging across different healthcare specialties and years of experience. Our study found that existing practice in ADR recurrence prevention was inadequate, and most healthcare workers were unaware of an alternative approach. Unique solutions were provided by the respondents, with the majority favouring a card format for preventing recurrence.
After being introduced to the ADR Alert Card, there was an overwhelming consensus on the utility and practicality of this card in preventing ADR recurrence.
药物不良反应（ADR）是导致发病和住院的主要独立原因之一，在很大程度上导致了医疗保健支出的增加。重复发生的药物不良反应事件，尽管难以量化，但却是一个公认的问题，会给患者带来可预防的痛苦。低收入/中等收入国家目前预防药物不良反应复发的方法效率低下甚至根本不存在。很少有文献关注此类环境下药物不良反应的可预防性。本研究旨在开发药物不良反应警示卡，这是一种经济创新，旨在作为预防药物不良反应复发的权宜之计，并通过医学专业人员的意见验证该系统来评估其效用。
药物不良反应警示卡已在印度政府版权局进行验证和注册。为了征求医疗保健专业人员的意见并了解预防药物不良反应复发的现状，我们进行了为期6个月的在线描述性横断面研究。
该调查共收到218份回复。受访者的人口统计学特征各不相同，涵盖不同的医疗专业和工作年限。我们的研究发现，目前预防药物不良反应复发的做法并不充分，大多数医护人员不知道还有其他方法。受访者提供了独特的解决方案，大多数人倾向于采用卡片形式来预防复发。
在了解了药物不良反应警示卡后，对于该卡在预防药物不良反应复发方面的效用和实用性，大家达成了压倒性的共识。
